Collaboration Revenue (Tables)

6 Months Ended

Jun. 30, 2023

Collaboration Revenue.

Schedule of collaboration revenue

	H1 2023	H1 2022
	$m	$m
Lynparza: regulatory milestones	-	175
COVID-19 mAbs: licence fees	180	-
Farxiga: sales milestones	25	-
tralokinumab: sales milestones	-	70
Other Collaboration Revenue	15	16
Total	220	261